extract from an article on Seeking Alpha
For the pediatric trial, however, there is really nothing left to discuss. The trial was a failure. How much of an effect the pediatric Rett data will have on the rest of the pipeline is anyone's guess, but for now, the stock has taken a terrible beating, going down losing 40% overnight.The company did try to explain the poor show by claiming a very strong placebo effect, but their reasons sounded hollow.
- Forums
- ASX - By Stock
- NEU
- ANAVEX MEETS ENDPOINTS PHASE2 RETT
ANAVEX MEETS ENDPOINTS PHASE2 RETT, page-167
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$20.71 |
Change
0.000(0.00%) |
Mkt cap ! $2.644B |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 350 | $30.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$19.68 | 45 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 350 | 30.000 |
1 | 50 | 23.000 |
1 | 25 | 22.000 |
1 | 500 | 21.620 |
1 | 51 | 21.610 |
Price($) | Vol. | No. |
---|---|---|
20.680 | 1 | 1 |
20.690 | 397 | 2 |
20.710 | 186 | 3 |
20.740 | 524 | 1 |
21.000 | 1500 | 1 |
Last trade - 16.16pm 24/05/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
Day chart unavailable